Insider Trading Alert - XYL, UMBF And PRGX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 5, 2015, 84 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.00 to $1,572,413.89.

Highlighted Stocks Traded by Insiders:

Xylem (XYL) - FREE Research Report

Speetzen Michael T, who is Chief Financial Officer & SVP at Xylem, sold 18,000 shares at $36.82 on May 5, 2015. Following this transaction, the Chief Financial Officer & SVP owned 49,601 shares meaning that the stake was reduced by 26.63% with the 18,000-share transaction.

The shares most recently traded at $36.59, down $0.23, or 0.63% since the insider transaction. Historical insider transactions for Xylem go as follows:

  • 4-Week # shares sold: 3,718
  • 12-Week # shares sold: 4,338
  • 24-Week # shares sold: 4,338

The average volume for Xylem has been 994,900 shares per day over the past 30 days. Xylem has a market cap of $6.7 billion and is part of the industrial goods sector and industrial industry. Shares are down 3.07% year-to-date as of the close of trading on Tuesday.

Xylem Inc. engages in the design, manufacture, and application of engineered technologies for the water and wastewater applications. The company operates in two segments, Water Infrastructure and Applied Water. The stock currently has a dividend yield of 1.53%. The company has a P/E ratio of 19.3. Currently, there are 5 analysts who rate Xylem a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XYL - FREE

TheStreet Quant Ratings rates Xylem as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Xylem Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

UMB Financial (UMBF) - FREE Research Report

Graves Greg M, who is Director at UMB Financial, bought 50 shares at $49.95 on May 5, 2015. Following this transaction, the Director owned 14,399 shares meaning that the stake was boosted by 0.35% with the 50-share transaction.

The shares most recently traded at $52.04, up $2.09, or 4.03% since the insider transaction. Historical insider transactions for UMB Financial go as follows:

  • 4-Week # shares bought: 58
  • 4-Week # shares sold: 3,011
  • 12-Week # shares bought: 58
  • 12-Week # shares sold: 3,011
  • 24-Week # shares bought: 235
  • 24-Week # shares sold: 3,011

The average volume for UMB Financial has been 159,800 shares per day over the past 30 days. UMB Financial has a market cap of $2.3 billion and is part of the financial sector and banking industry. Shares are down 10.53% year-to-date as of the close of trading on Tuesday.

UMB Financial Corporation, through its subsidiaries, provides various banking and other financial products and services in the United States and internationally. It operates through four segments: Bank, Payment Solutions, Institutional Investment Management, and Asset Servicing. The stock currently has a dividend yield of 1.85%. The company has a P/E ratio of 17.7. Currently, there is 1 analyst who rates UMB Financial a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UMBF - FREE

TheStreet Quant Ratings rates UMB Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full UMB Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

PRGX Global (PRGX) - FREE Research Report

Whitters Joseph E, who is Director at PRGX Global, bought 12,500 shares at $4.30 on May 5, 2015. Following this transaction, the Director owned 108,153 shares meaning that the stake was boosted by 13.07% with the 12,500-share transaction.

The shares most recently traded at $4.40, up $0.10, or 2.27% since the insider transaction. Historical insider transactions for PRGX Global go as follows:

  • 4-Week # shares bought: 40,000
  • 4-Week # shares sold: 23,860
  • 12-Week # shares bought: 83,600
  • 12-Week # shares sold: 23,860
  • 24-Week # shares bought: 123,600
  • 24-Week # shares sold: 23,860

The average volume for PRGX Global has been 140,200 shares per day over the past 30 days. PRGX Global has a market cap of $112.4 million and is part of the services sector and diversified services industry. Shares are down 23.43% year-to-date as of the close of trading on Tuesday.

PRGX Global, Inc., together with its subsidiaries, provides recovery audit services to businesses and government agencies having payment transactions and procurement environments in the United States, Canada, Latin America, Europe, Asia, and the Pacific region. Currently, there is 1 analyst who rates PRGX Global a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRGX - FREE

TheStreet Quant Ratings rates PRGX Global as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full PRGX Global Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Data for this article provided by Zacks Investment Research

If you liked this article you might like

13 Stocks Investors Should Short if Inflation Remains Low

13 Stocks Investors Should Short if Inflation Remains Low

Buy on Weakness: Cramer's 'Mad Money' Recap (Thursday 10/19/17)

Buy on Weakness: Cramer's 'Mad Money' Recap (Thursday 10/19/17)

Domino's Pizza, Xylem, Incyte, Mercadolibre: 'Mad Money' Lightning Round

Domino's Pizza, Xylem, Incyte, Mercadolibre: 'Mad Money' Lightning Round

Navigating Strong Crosscurrents: Cramer's 'Mad Money' Recap (Tuesday 6/13/17)

Navigating Strong Crosscurrents: Cramer's 'Mad Money' Recap (Tuesday 6/13/17)